A practical reference on Kjeldahl method: what it is, how it behaves, what the literature reports, and where the honest uncertainties sit.
This page was last updated on 2026-02-01 and is reviewed periodically as new material appears.
Storage stability depends on moisture, temperature, and exposure to oxygen. Dry hydrolysate powders are hygroscopic and can clump or cake when humidity is high. Moisture also promotes Maillard reactions between peptides and residual lactose, leading to browning and flavor changes. Cool, dry, sealed storage slows these reactions, while prolonged warmth can increase off-flavors and reduce solubility. Stability studies often track color, moisture, free amino groups, and microbial load over time to estimate shelf life.
Quality control includes verifying identity, protein content, degree of hydrolysis, and absence of contaminants. Because hydrolysates are often used in foods and supplements, regulations may treat them as food ingredients rather than drugs. Allergen labeling rules can vary, and highly hydrolyzed products are sometimes considered less allergenic, but this depends on peptide size and clinical testing. Sourcing documents should link each lot to raw whey, enzymes, and processing conditions. Independent verification is useful because analytical results can shift with method and laboratory.
Laboratories characterize whey protein hydrolysate using several complementary methods. Nitrogen determination estimates total protein, while size-exclusion chromatography and mass spectrometry reveal peptide size distributions. Degree of hydrolysis can be calculated from free amino groups, pH change, or osmolarity, but each approach has assumptions. Moisture, ash, and mineral content are also measured because they affect shelf life and reconstitution. No single test fully describes a hydrolysate, so specifications usually combine several results.
Quality control for hydrolysates often includes allergen and contaminant checks. Because whey is a milk-derived ingredient, milk protein residues may remain, and the extent to which hydrolysis reduces allergenic potential is product-specific and not fully predictable. Tests may screen for heavy metals, melamine, pesticides, and microbial indicators. Enzyme residues and processing aids are also monitored when regulations require it. Batch-to-batch consistency is assessed through peptide mapping or functional tests, since small process changes can alter taste, solubility, or nutritional performance.
Laboratories characterize whey protein hydrolysate by several complementary methods. Total nitrogen or Kjeldahl analysis estimates crude protein, while amino acid analysis gives a more detailed composition. Size-exclusion chromatography and mass spectrometry separate peptides by molecular weight and can reveal the distribution of chain lengths. Degree of hydrolysis is often calculated from free amino groups using trinitrobenzenesulfonic acid or o-phthaldialdehyde assays. No single measurement captures all relevant properties, so specifications usually combine protein content, peptide profile, moisture, ash, and microbial limits.
Storage stability depends on moisture, temperature, oxygen, and packaging. Dry hydrolysate powders are typically stable for months to years when kept cool and sealed, but they can absorb water and cake if exposed to humid air. Higher temperatures accelerate Maillard reactions between peptides and residual sugars, leading to browning and flavor changes. Lipid oxidation can occur if residual fat is present, producing off-odors. Once a powder is reconstituted, microbial growth becomes a concern, so liquid forms require refrigeration or other preservation steps.
| Property | Value | Notes |
|---|---|---|
| Moisture content | 3-7% typical | Lower moisture extends shelf life |
| pH (5% solution) | 6.0-7.5 | Varies with ash and processing |
| Storage condition | 15-25 °C, dry, sealed | Protect from humidity and odors |
| Common analytical method | Size-exclusion chromatography | Estimates peptide size distribution |
| Microbial limit | Typically <10^4 CFU/g | Product-specific and regional limits apply |
Hydrolysate powders are hygroscopic and can absorb moisture during storage, which may promote caking, browning, and loss of solubility. Cool, dry conditions and sealed packaging slow these changes, while high humidity and warm temperatures accelerate Maillard reactions between peptides and residual sugars. Liquid hydrolysates are more perishable and often require refrigeration or preservatives. Shelf-life studies usually monitor moisture, color, solubility, free amino groups, and microbial load over time. Stability depends on residual lactose, water activity, packaging barrier properties, and the initial peptide profile.
Degree of hydrolysis is commonly estimated by titrating liberated carboxyl groups, measuring soluble nitrogen in trichloroacetic acid, or using o-phthaldialdehyde assays. Molecular weight distribution is often examined by size-exclusion chromatography, sodium dodecyl sulfate polyacrylamide gel electrophoresis, or mass spectrometry. These methods answer different questions: titration estimates bond cleavage, while chromatography describes peptide size ranges. Because no single reference method is universally applied, values reported by different laboratories may not be directly comparable. Method details such as calibration standards and sample preparation strongly influence results.
Quality control focuses on degree of hydrolysis, molecular weight distribution, protein content, moisture, ash, and microbial limits. Degree of hydrolysis is commonly calculated from the number of cleaved peptide bonds relative to total peptide bonds. Size-exclusion chromatography and mass spectrometry can describe peptide size ranges, while amino acid analysis quantifies composition. Standard methods from dairy science organizations are often used, though no single method captures every functional property. Results are therefore reported alongside processing conditions.
Hydrolysates are generally stable as dry powders but can absorb moisture and undergo browning during warm storage. The bitter taste of some hydrolysates arises from hydrophobic peptides exposed by cleavage, and it varies with enzyme choice and degree of hydrolysis. Reduced allergenicity is sometimes claimed, but residual IgE-binding peptides may remain, especially in partial hydrolysates. Regulatory frameworks treat extensively hydrolyzed and partially hydrolyzed products differently, and labeling rules vary by country. More research is needed on how specific peptide profiles relate to clinical outcomes.
Commercial production begins with whey protein concentrate or isolate dissolved in water. A protease is added under controlled pH and temperature, and the reaction is stopped by heat or pH adjustment once a target degree of hydrolysis is reached. Membrane filtration, often ultrafiltration or diafiltration, removes enzymes and small solutes while retaining peptides. The liquid is then concentrated and spray-dried into a powder. Each step influences peptide length, mineral content, and flavor.
Physical properties such as particle size, bulk density, and reconstitution behavior affect handling and finished product quality. Water activity and moisture content influence shelf life; high moisture can promote caking, browning, and microbial growth. Color is monitored because Maillard reactions between peptides and reducing sugars can darken the powder during storage. Taste panels and instrumental methods may assess bitterness, which is a common challenge for hydrolysates. Specifications often include limits for heavy metals, microbiological counts, and residual fat, depending on the intended market.
Quality control for hydrolyzed whey protein focuses on composition, peptide size, and batch consistency. Protein content is commonly measured by Kjeldahl or combustion analysis, while moisture and ash are determined by gravimetric methods. Peptide molecular weight distribution is often assessed by size exclusion chromatography or mass spectrometry. The extent of hydrolysis can be estimated by titration, trinitrobenzenesulfonic acid assays, or formol titration. Because hydrolysis produces a complex mixture, no single test captures every relevant property, and laboratories often combine several methods.
A 2013 study found DMT in microdialysate obtained from a rat's pineal gland, providing evidence of endogenous DMT in the mammalian brain. In 2019, experiments showed that the rat brain is capable of synthesizing and releasing DMT. These results raise the possibility that this phenomenon may occur similarly in human brains. Quantities of dimethyltryptamine and O-methylbufotenin were found present in the cerebrospinal fluid of humans in a 1978 psychiatric study.
29 September Last Neanderthal?, the unanswered question of the Neanderthal extinction, with Sir Paul Mellars of the University of Cambridge; Pat Shipman of Penn State University; science writer James Shreeve; anthropologist Randall White of New York University; the first complete skeleton was found in 1908 and given to Marcellin Boule; Milford H.
Epitalon is a synthetic peptide, telomerase activator, and putative anti-aging compound, which was identified as the putative active component of a bovine pineal gland extract known as epithalamin. Most studies on epitalon and epithalamin have been conducted by the St. Petersburg Institute of Bioregulation and Gerontology, primarily overseen by Vladimir Khavinson, in Russia, though in recent years research using epitalon has started to be conducted elsewhere, focusing mainly on its ability to extend telomere length.
=== Blood pressure === Serum vitamin C was reported to be 15.13 μmol/L lower in people with hypertension compared to normotensives. The vitamin was inversely associated with both systolic blood pressure (SBP) and diastolic blood pressure (DBP). Oral supplementation of the vitamin resulted in a modest but statistically significant decrease in SBP in people with hypertension. The proposed explanation is that vitamin C increases intracellular concentrations of tetrahydrobiopterin, an endothelial nitric oxide synthase cofactor that promotes the production of nitric oxide, which is a potent vasodilator. Vitamin C supplementation might also reverse the nitric oxide synthase inhibitor NG-monomethyl-L-arginine 1, and there is also evidence cited that vitamin C directly enhances the biological activity of nitric oxide.
== Treatment == The goal of glaucoma management for patients with increased intraocular pressure is to decrease the intraocular pressure (IOP), thus slowing the progression of glaucoma and preserving the quality of life for patients, with minimal side-effects. This requires appropriate diagnostic techniques and follow-up examinations, and judicious selection of treatments for the individual patient. Although increased IOP is only one of the major risk factors for glaucoma, lowering it via various pharmaceuticals and/or surgical techniques is currently the mainstay of glaucoma treatment. Vascular flow and neurodegenerative theories of glaucomatous optic neuropathy have prompted studies on various neuroprotective therapeutic strategies, including nutritional compounds, some of which may be regarded by clinicians as safe for use now, while others are on trial. Mental stress is also considered as consequence and cause of vision loss which means that stress management training, autogenic training and other techniques to cope with stress can be helpful.
Sources: en.wikipedia.org
Pivampicillin (pivaloyloxymethyl ester of ampicillin) Bacampicillin Metampicillin (formaldehyde ester of ampicillin) Talampicillin Hetacillin (ampicillin conjugated to acetone) Epicillin is an aminopenicillin that has never seen widespread clinical use.
the adenovirus carrier in all samples was actually able to replicate in spite of manufacturer's declaration it was incapacitated the methodology used by Gamaleya to check immune system response was unreliable and documentation provided made its verification impossible the procedure of registering adverse effects was insufficient Anvisa delegation was also not allowed into the Gamaleya laboratory for inspection all presented studies were performed on vaccine doses produced in laboratory, rather than in the manufacturing facility supplying vaccine for the mass market, which makes the results not representative Anvisa found issues in one of the factories in Russia that could impact sterility of the doses. On 29 April 2021, the developers of Sputnik V said that Anvisa admitted not testing Sputnik V and that they would sue Anvisa in Brazil for defamation. At a press conference, Anvisa officials said that Gamaleya's own documents indicated multiple times the presence of replication-competent adenoviruses (RCAs) in ready vaccine batches and that the specifications accepted a level of RCAs 300 times greater than any other regulatory threshold. Anvisa presented the video of a meeting with representatives from Russia and Brazil where, when asked about the presence of RCAs, a representative from Russia reported problems with the cells and said that the vaccine could have been redeveloped, but it would take too long, so the developers instead chose to continue the research imposing an acceptable level of RCAs.
Net protein Utilization (NPU) Protein Efficiency Ratio (PER) Nitrogen Balance (NB) Protein digestibility (PD) Protein Digestibility Corrected Amino Acid Score (PDCAAS) Digestible Indispensable Amino Acid Score (DIAAS) These all hold specific advantages and disadvantages over BV, although in the past BV has been held in high regard.
The creation of British Nationality (Overseas) status, for instance, (with fewer privileges than British citizen status) was met with criticism from many Hong Kong residents who felt that British citizenship would have been more appropriate in light of the "moral debt" owed to them by the UK. Some British politicians and magazines also criticised the creation of BN(O) status. In 2020, the British government under Boris Johnson announced a program under which BN(O)s would have leave to remain in the UK with rights to work and study for five years, after which they may apply for settled status. They would then be eligible for full citizenship after holding settled status for 12 months. This was implemented as the eponymously named "British National (Overseas) visa", a residence permit that BN(O)s and their dependent family members have been able to apply for since 31 January 2021. BN(O)s and their dependents who arrived in the UK before the new immigration route became available were granted "Leave Outside the Rules" at the discretion of the Border Force to remain in the country for up to six months as a temporary measure. In effect, this retroactively granted BN(O)s a path to right of abode in the United Kingdom. Despite the COVID-19 pandemic, about 7,000 people had entered the UK under this scheme between July 2020 and January 2021.
palindromic sequence Also palindrome. A nucleic acid sequence of a double-stranded DNA or RNA molecule in which the unidirectional sequence (e.g. 5' to 3') of nucleobases on one strand is identical to the sequence in the same direction (e.g. 5' to 3') on the complementary strand. In other words, a sequence is said to be palindromic if it is equal to its own reverse complement. Palindromic motifs are common recognition sites for restriction enzymes.
Sources: en.wikipedia.org
== Research == Flupirtine has been noted for its neuroprotective properties, and has been investigated for possible use in Creutzfeldt–Jakob disease, Alzheimer's disease, and multiple sclerosis. It has also been proposed as a possible treatment for Batten disease. Flupirtine underwent a clinical trial as a treatment for multiple sclerosis and fibromyalgia. Flupirtine showed promise for fibromyalgia due to its different action than the three approved by U.S. FDA drugs: pregabalin, milnacipran, and duloxetine. Additionally, there are case reports regarding flupirtine as a treatment for fibromyalgia. Adeona Pharmaceuticals (now called Synthetic Biologics) sub-licensed its patents for using flupirtine for fibromyalgia to Meda AB in May 2010.
== Steric complementarity == In her third paper on cyclols (1936), Wrinch noted that many "physiologically active" substances such as steroids are composed of fused hexagonal rings of carbon atoms and, thus, might be sterically complementary to the face of cyclol molecules without the amino-acid side chains. Wrinch proposed that steric complementarity was one of chief factors in determining whether a small molecule would bind to a protein. Wrinch speculated that proteins are responsible for the synthesis of all biological molecules. Noting that cells digest their proteins only under extreme starvation conditions, Wrinch further speculated that life could not exist without proteins.
=== VUV detectors for gas chromatography detectors === VUV detectors are compatible with most gas chromatography (GC) manufacturers. The detectors can be connected through a heated transfer line inserted through a punch-out in the GC oven casing. A makeup flow of carrier gas is introduced at the end of the transfer line. Analytes arrive in the flow cell and are exposed to VUV light from a deuterium lamp. Specially coated reflective optics paired with a back-thinned charge-coupled device (CCD) enable the collection of high-quality VUV absorption data. Figure 1 shows a schematic of the analyte path from GC to VUV detector.
=== Absorbability === Aspect ratio affects the ability of the nanocapsule to penetrate tumor cells. Low aspect ratios (spherical capsules) tend to penetrate cells more easily than high aspect ratios (rod-shaped capsules).
Sources: en.wikipedia.org
Common methods quantify free amino groups, pH change, or osmolarity during or after hydrolysis. Each method uses different assumptions and can yield different values for the same sample. For this reason, degree of hydrolysis should be reported with the method used.
Hydrolysate powders attract moisture because short peptides and residual minerals are hygroscopic. High humidity causes particles to stick, cake, and sometimes dissolve partially. Sealed packaging with a moisture barrier reduces this problem.
Labeling rules vary by country and by product type. Some jurisdictions allow reduced-allergen claims only when clinical and analytical evidence supports them. Hydrolysis alone does not guarantee that a product is safe for people with milk allergy.
Degree of hydrolysis is commonly estimated by quantifying free amino groups with colorimetric assays such as o-phthaldialdehyde or trinitrobenzenesulfonic acid. The result is expressed as a percentage of total peptide bonds cleaved. Because different assays can give different values, method details matter when comparing products.